Literature DB >> 22187953

Possible role of interleukin-17 in the pathogenesis of lichen planus.

O Shaker, A S Hassan.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22187953     DOI： 10.1111/j.1365-2133.2011.10793.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  6 in total

1.  JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases.

Authors:  Ana Karina Alves de Medeiros; Reinhart Speeckaert; Eline Desmet; Mireille Van Gele; Sofie De Schepper; Jo Lambert
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

2.  Therapeutic Targeting of Th17/Tc17 Cells Leads to Clinical Improvement of Lichen Planus.

Authors:  Farzan Solimani; Robert Pollmann; Thomas Schmidt; Ansgar Schmidt; Xiang Zheng; Rajkumar Savai; Stefan Mühlenbein; Julia Pickert; Verena Eubel; Christian Möbs; Rüdiger Eming; Michael Hertl
Journal:  Front Immunol       Date:  2019-07-31       Impact factor: 7.561

Review 3.  Emerging Topical and Systemic JAK Inhibitors in Dermatology.

Authors:  Farzan Solimani; Katharina Meier; Kamran Ghoreschi
Journal:  Front Immunol       Date:  2019-12-03       Impact factor: 7.561

4.  Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study.

Authors:  Raluca Cosgarea; Robert Pollmann; Jusra Sharif; Thomas Schmidt; Ronja Stein; Aura Bodea; Thorsten Auschill; Anton Sculean; Rüdiger Eming; Brandon Greene; Michael Hertl; Nicole Arweiler
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

5.  Serum Level of Interleukin 17 in Patients with Erosive and Non erosive Oral Lichen Planus.

Authors:  Firoz Pouralibaba; Zohre Babaloo; Farzaneh Pakdel; Marziye Aghazadeh
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2013-05-30

6.  Increased Serum Level and High Tissue Immunoexpression of Interleukin 17 in Cutaneous Lichen Planus: A Novel Therapeutic Target for Recalcitrant Cases?

Authors:  Magdalena Żychowska; Aleksandra Batycka-Baran; Wojciech Baran
Journal:  Dis Markers       Date:  2020-07-24       Impact factor: 3.434
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.